Kardigan Earnings Call Transcripts

Fiscal Year 2026

12th Annual Cantor Fitzgerald Global Healthcare Conference

A platform-focused cardiovascular innovator highlighted its late-stage pipeline in genetic cardiomyopathy and aortic stenosis, leveraging adaptive trial designs and real-world data integration. Key programs danicamtiv and ataciguat are advancing through pivotal trials, with major data readouts expected next year.

Read full transcript →